BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1947738)

  • 1. "Matrix effects" in immunoassays.
    Wood WG
    Scand J Clin Lab Invest Suppl; 1991; 205():105-12. PubMed ID: 1947738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010.
    Hermsen D; Franzson L; Hoffmann JP; Isaksson A; Kaufman JM; Leary E; Müller C; Nakatsuka K; Nishizawa Y; Reinauer H; Riesen W; Roth HJ; Steinmüller T; Troch T; Bergmann P
    Clin Lab; 2002; 48(3-4):131-41. PubMed ID: 11934215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAP survey of parathyroid hormone assays.
    Klee GG; Shikegawa J; Trainer TD
    Arch Pathol Lab Med; 1986 Jul; 110(7):588-91. PubMed ID: 3755023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of recombinant human parathyroid hormone (rhPTH(1-84)) in human plasma by immunoassay: commercial kit evaluation and validation to support pharmacokinetic studies.
    Sukovaty RL; Lee JW; Fox J; Toney K; Papac DI; Grover TA; Wells DS
    J Pharm Biomed Anal; 2006 Sep; 42(2):261-71. PubMed ID: 16765549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoassays for the detection of parathyroid hormone.
    Jüppner H; Potts JT
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N81-6. PubMed ID: 12412782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can chemiluminescent immunoanalysis of thyroid hormones stand for a reference method?
    Schneiderka P; Bezdícková D; Uhrová J
    Sb Lek; 1994; 95(4):363-72. PubMed ID: 8867708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External quality assessment of serum hormone determinations in the Nordic countries.
    Ruokonen A; Leskinen E; Nyberg A; Vihko R
    Scand J Clin Lab Invest Suppl; 1984; 172():125-34. PubMed ID: 6599513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Difficulties and problems in external quality control of immunoassay].
    Itoh C
    Rinsho Byori; 1993 May; 41(5):583-7. PubMed ID: 8350528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methodological evaluation of a new chemiluminescence immunoassay for thyrotropin using acridinium ester-labelled antibody.
    Zucchelli GC; Pilo A; Masini S; Chiesa MR; Masi A
    J Biolumin Chemilumin; 1989 Jul; 4(1):620-6. PubMed ID: 2801247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunoassay of cytokines and growth factors in biological fluids.
    Kopp W; Reynolds C; Ruscetti F
    Dev Biol Stand; 1999; 97():29-37. PubMed ID: 10463528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferences in hormone immunoassays.
    Klee GG
    Clin Lab Med; 2004 Mar; 24(1):1-18. PubMed ID: 15157554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combination of labeled and unlabeled antibody enables self-calibration and reduction of sample matrix effects in immunoassay.
    Glass TR; Ohmura N; Saiki H; Lackie SJ
    Anal Biochem; 2004 Aug; 331(1):68-76. PubMed ID: 15245998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid hormone reference intervals in an ambulatory Arab population on the Abbott Architect i2000 immunoassay analyzer.
    Dhatt GS; Griffin G; Agarwal MM
    Clin Chim Acta; 2006 Feb; 364(1-2):226-9. PubMed ID: 16098499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nature of calibrators in immunoassays: are they commutable with test samples? Must they be?
    Rej R; Drake P
    Scand J Clin Lab Invest Suppl; 1991; 205():47-54. PubMed ID: 1947748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Traceability and standardization of immunoassays: a major challenge.
    Morris HA
    Clin Biochem; 2009 Mar; 42(4-5):241-5. PubMed ID: 19863913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Has the introduction of the European Parliament Directive 98/79/EC from 1998-10-27--concerning in-vitro diagnostic devices (IVD-directive) influenced performance of hormone immunoassay kits in terms of precision and accuracy? Results from selected external quality assessment (EQA) schemes between 1993 and 2008.
    Wood WG
    Clin Lab; 2009; 55(3-4):86-105. PubMed ID: 19462931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LIAISON hCG--an automated chemiluminescent immunoassay for the determination of human chorionic gonadotropin (hCG).
    Oed M; Amtmann R; Löwer Y; Schlett R; Mack M
    Anticancer Res; 1999; 19(4A):2735-7. PubMed ID: 10470231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of parathyroid hormone.
    Endres DB; Villanueva R; Sharp CF; Singer FR
    Endocrinol Metab Clin North Am; 1989 Sep; 18(3):611-29. PubMed ID: 2673765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of free hormone fractions by an ultrafast immunoextraction/displacement immunoassay: studies using free thyroxine as a model system.
    Clarke W; Schiel JE; Moser A; Hage DS
    Anal Chem; 2005 Mar; 77(6):1859-66. PubMed ID: 15762597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two cases of antiruthenium antibody interference in Modular free thyroxine assay.
    Heijboer AC; Ijzerman RG; Bouman AA; Blankenstein MA
    Ann Clin Biochem; 2009 May; 46(Pt 3):263-4. PubMed ID: 19261677
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.